How much revenue does Sanofi Cons Healthc IND L make?

Sanofi Cons Healthc IND L reported 7.16 billion INR in revenue for fiscal year 2024, up 31.6% from 5.44 billion INR in fiscal year 2023. In Q3 2025 revenue was 2.34 billion INR.

Where does Sanofi Cons Healthc IND L make most of its revenue?

India: 91% of revenue by region in fiscal year 2024, followed by Outside India (9%).

What companies are similar to Sanofi Cons Healthc IND L?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Jubilant Pharmova Limited (JUBLPHARMA.NS), Natco Pharma Limited (NATCOPHARM.NS), Strides Pharma Science Limited (STAR.NS), Sanofi India Limited (SANOFI.NS).

Sanofi Cons Healthc IND L (SANOFICONR.BO) Stock

About Sanofi Cons Healthc IND L

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorp...

At a glance

Sanofi Cons Healthc IND L reported revenue of 7.16 billion INR for fiscal year 2024, up 31.6% from fiscal year 2023, and net income of 1.81 billion INR. In Q3 2025 (the quarter ended September 30, 2025) revenue was 2.34 billion INR, up 46.3% from a year before. India was its largest region in fiscal year 2024, with 91% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2024.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.